Covid-19 Impact on Global In Vitro Organ Preservation Market Size, Status and Forecast 2020-2026
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered: Ranking by In Vitro Organ Preservation Revenue
- 1.4 Covid-19 Implications on Market by Type
- 1.4.1 Global In Vitro Organ Preservation Market Size Growth Rate by Type: 2020 VS 2026
- 1.4.2 Static Cold Storage
- 1.4.3 Hypothermic Machine Perfusion
- 1.4.4 Normothermic Machine Perfusion
- 1.5 Market by Application
- 1.5.1 Global In Vitro Organ Preservation Market Share by Application: 2020 VS 2026
- 1.5.2 Kidneys
- 1.5.3 Liver
- 1.5.4 Lung
- 1.5.5 Heart
- 1.5.6 Others (Intestine & Pancreas)
- 1.6 Coronavirus Disease 2019 (Covid-19): In Vitro Organ Preservation Industry Impact
- 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
- 1.6.2 Covid-19 Impact: Commodity Prices Indices
- 1.6.3 Covid-19 Impact: Global Major Government Policy
- 1.7 Study Objectives
- 1.8 Years Considered
2 Global Growth Trends
- 2.1 Covid-19 Implications on Global In Vitro Organ Preservation Market Perspective (2015-2026)
- 2.2 Covid-19 Implications on Global In Vitro Organ Preservation Growth Trends by Regions
- 2.2.1 In Vitro Organ Preservation Market Size by Regions: 2015 VS 2020 VS 2026
- 2.2.2 In Vitro Organ Preservation Historic Market Share by Regions (2015-2020)
- 2.2.3 In Vitro Organ Preservation Forecasted Market Size by Regions (2021-2026)
- 2.3 Industry Trends and Growth Strategy
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
- 2.3.5 In Vitro Organ Preservation Market Growth Strategy
- 2.3.6 Primary Interviews with Key In Vitro Organ Preservation Players (Opinion Leaders)
3 Covid-19 Implications on Competition Landscape by Key Players
- 3.1 Global Top In Vitro Organ Preservation Players by Market Size
- 3.1.1 Global Top In Vitro Organ Preservation Players by Revenue (2015-2020)
- 3.1.2 Global In Vitro Organ Preservation Revenue Market Share by Players (2015-2020)
- 3.1.3 Global In Vitro Organ Preservation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.2 Global In Vitro Organ Preservation Market Concentration Ratio
- 3.2.1 Global In Vitro Organ Preservation Market Concentration Ratio (CR5 and HHI)
- 3.2.2 Global Top 10 and Top 5 Companies by In Vitro Organ Preservation Revenue in 2019
- 3.3 In Vitro Organ Preservation Key Players Head office and Area Served
- 3.4 Key Players In Vitro Organ Preservation Product Solution and Service
- 3.5 Date of Enter into In Vitro Organ Preservation Market
- 3.6 Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
- 4.1 Global In Vitro Organ Preservation Historic Market Size by Type (2015-2020)
- 4.2 Global In Vitro Organ Preservation Forecasted Market Size by Type (2021-2026)
5 Covid-19 Implications on Market Size by Application (2015-2026)
- 5.1 Global In Vitro Organ Preservation Market Size by Application (2015-2020)
- 5.2 Global In Vitro Organ Preservation Forecasted Market Size by Application (2021-2026)
6 North America Impact of COVID-19
- 6.1 North America In Vitro Organ Preservation Market Size (2015-2020)
- 6.2 In Vitro Organ Preservation Key Players in North America (2019-2020)
- 6.3 North America In Vitro Organ Preservation Market Size by Type (2015-2020)
- 6.4 North America In Vitro Organ Preservation Market Size by Application (2015-2020)
7 Europe Impact of COVID-19
- 7.1 Europe In Vitro Organ Preservation Market Size (2015-2020)
- 7.2 In Vitro Organ Preservation Key Players in Europe (2019-2020)
- 7.3 Europe In Vitro Organ Preservation Market Size by Type (2015-2020)
- 7.4 Europe In Vitro Organ Preservation Market Size by Application (2015-2020)
8 China Impact of COVID-19
- 8.1 China In Vitro Organ Preservation Market Size (2015-2020)
- 8.2 In Vitro Organ Preservation Key Players in China (2019-2020)
- 8.3 China In Vitro Organ Preservation Market Size by Type (2015-2020)
- 8.4 China In Vitro Organ Preservation Market Size by Application (2015-2020)
9 Japan Impact of COVID-19
- 9.1 Japan In Vitro Organ Preservation Market Size (2015-2020)
- 9.2 In Vitro Organ Preservation Key Players in Japan (2019-2020)
- 9.3 Japan In Vitro Organ Preservation Market Size by Type (2015-2020)
- 9.4 Japan In Vitro Organ Preservation Market Size by Application (2015-2020)
10 Southeast Asia Impact of COVID-19
- 10.1 Southeast Asia In Vitro Organ Preservation Market Size (2015-2020)
- 10.2 In Vitro Organ Preservation Key Players in Southeast Asia (2019-2020)
- 10.3 Southeast Asia In Vitro Organ Preservation Market Size by Type (2015-2020)
- 10.4 Southeast Asia In Vitro Organ Preservation Market Size by Application (2015-2020)
11 India Impact of COVID-19
- 11.1 India In Vitro Organ Preservation Market Size (2015-2020)
- 11.2 In Vitro Organ Preservation Key Players in India (2019-2020)
- 11.3 India In Vitro Organ Preservation Market Size by Type (2015-2020)
- 11.4 India In Vitro Organ Preservation Market Size by Application (2015-2020)
12 Central & South America Impact of COVID-19
- 12.1 Central & South America In Vitro Organ Preservation Market Size (2015-2020)
- 12.2 In Vitro Organ Preservation Key Players in Central & South America (2019-2020)
- 12.3 Central & South America In Vitro Organ Preservation Market Size by Type (2015-2020)
- 12.4 Central & South America In Vitro Organ Preservation Market Size by Application (2015-2020)
13Key Players Profiles
- 13.1 Xvivo Perfusion
- 13.1.1 Xvivo Perfusion Company Details
- 13.1.2 Xvivo Perfusion Business Overview and Its Total Revenue
- 13.1.3 Xvivo Perfusion In Vitro Organ Preservation Introduction
- 13.1.4 Xvivo Perfusion Revenue in In Vitro Organ Preservation Business (2015-2020))
- 13.1.5 Xvivo Perfusion Recent Development and Reaction to COVID-19
- 13.2 Paragonix Technologies
- 13.2.1 Paragonix Technologies Company Details
- 13.2.2 Paragonix Technologies Business Overview and Its Total Revenue
- 13.2.3 Paragonix Technologies In Vitro Organ Preservation Introduction
- 13.2.4 Paragonix Technologies Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.2.5 Paragonix Technologies Recent Development and Reaction to COVID-19
- 13.3 Dr. Franz Köhler Chemie GMBH
- 13.3.1 Dr. Franz Köhler Chemie GMBH Company Details
- 13.3.2 Dr. Franz Köhler Chemie GMBH Business Overview and Its Total Revenue
- 13.3.3 Dr. Franz Köhler Chemie GMBH In Vitro Organ Preservation Introduction
- 13.3.4 Dr. Franz Köhler Chemie GMBH Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.3.5 Dr. Franz Köhler Chemie GMBH Recent Development and Reaction to COVID-19
- 13.4 Essential Pharmaceuticals
- 13.4.1 Essential Pharmaceuticals Company Details
- 13.4.2 Essential Pharmaceuticals Business Overview and Its Total Revenue
- 13.4.3 Essential Pharmaceuticals In Vitro Organ Preservation Introduction
- 13.4.4 Essential Pharmaceuticals Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.4.5 Essential Pharmaceuticals Recent Development and Reaction to COVID-19
- 13.5 Transmedics
- 13.5.1 Transmedics Company Details
- 13.5.2 Transmedics Business Overview and Its Total Revenue
- 13.5.3 Transmedics In Vitro Organ Preservation Introduction
- 13.5.4 Transmedics Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.5.5 Transmedics Recent Development and Reaction to COVID-19
- 13.6 Organox Limited
- 13.6.1 Organox Limited Company Details
- 13.6.2 Organox Limited Business Overview and Its Total Revenue
- 13.6.3 Organox Limited In Vitro Organ Preservation Introduction
- 13.6.4 Organox Limited Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.6.5 Organox Limited Recent Development and Reaction to COVID-19
- 13.7 Shanghai Genext Medical Technology
- 13.7.1 Shanghai Genext Medical Technology Company Details
- 13.7.2 Shanghai Genext Medical Technology Business Overview and Its Total Revenue
- 13.7.3 Shanghai Genext Medical Technology In Vitro Organ Preservation Introduction
- 13.7.4 Shanghai Genext Medical Technology Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.7.5 Shanghai Genext Medical Technology Recent Development and Reaction to COVID-19
- 13.8 Waters Medical Systems
- 13.8.1 Waters Medical Systems Company Details
- 13.8.2 Waters Medical Systems Business Overview and Its Total Revenue
- 13.8.3 Waters Medical Systems In Vitro Organ Preservation Introduction
- 13.8.4 Waters Medical Systems Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.8.5 Waters Medical Systems Recent Development and Reaction to COVID-19
- 13.9 Transplant Biomedicals
- 13.9.1 Transplant Biomedicals Company Details
- 13.9.2 Transplant Biomedicals Business Overview and Its Total Revenue
- 13.9.3 Transplant Biomedicals In Vitro Organ Preservation Introduction
- 13.9.4 Transplant Biomedicals Revenue in In Vitro Organ Preservation Business (2015-2020)
- 13.9.5 Transplant Biomedicals Recent Development and Reaction to COVID-19
14Analyst's Viewpoints/Conclusions
15Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.2 Data Source
- 15.2 Disclaimer
In Vitro Organ Preservation market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global In Vitro Organ Preservation market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the In Vitro Organ Preservation market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the In Vitro Organ Preservation industry.
The key players covered in this study
Xvivo Perfusion
Paragonix Technologies
Dr. Franz Köhler Chemie GMBH
Essential Pharmaceuticals
Transmedics
Organox Limited
Shanghai Genext Medical Technology
Waters Medical Systems
Transplant Biomedicals
Market segment by Type, the product can be split into
Static Cold Storage
Hypothermic Machine Perfusion
Normothermic Machine Perfusion
Market segment by Application, split into
Kidneys
Liver
Lung
Heart
Others (Intestine & Pancreas)
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global In Vitro Organ Preservation status, future forecast, growth opportunity, key market and key players.
To present the In Vitro Organ Preservation development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of In Vitro Organ Preservation are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.